Latest

Biopharma firms favour European contract manufacturing over US sites despite tariff pressure

US contract manufacturing deals for FDA-approved drugs hit a five-year low in 2025, as biopharma companies (including major US-headquartered firms) increasingly direct outsourced production to European facilities, new GlobalData analysis reveals

Find out more

Applied Biopharm Consulting awarded Innovation funding to validate...

Irish biotech consultancy Applied Biopharm Consulting has secured an Innovation Voucher from the Local Enterprise...
See more

Touchlight partners with SVF Vaccines to advance dual hepatitis B/D vaccine into clinical development

The pair will progress an innovative dual-targeting hepatitis B and D vaccine into clinical trials, leveraging Touchlight's enzymatic doggybone DNA platform, which has demonstrated significant dose-sparing potential compared to traditional plasmid DNA

Oxford BioTherapeutics signs T-cell engager collaboration with Bristol Myers Squibb for solid tumour targets

The company has entered a multi-year collaboration with BMS to discover and develop next-generation T-cell engager therapies for solid tumours using its OGAP-Verify platform, marking the company's third major pharma partnership in twelve months following deals with GSK and Roche

An integrated path: how CDMOs are reshaping complex drug development

The pharmaceutical CDMO sector is rapidly evolving toward integrated, end-to-end partnerships that align development, manufacturing, packaging and supply to meet the growing complexity, cost pressures and scalability demands of advanced biologics and precision therapies

First CAR-T therapy for solid tumours set to launch in China

Claudin18.2-targeting CAR-T therapy satri-cel (CT041) is expected to become the first treatment of its kind for solid tumours, offering a new option for patients with advanced gastrointestinal cancers

Virica Biotech and FUJIFILM Biosciences collaborate to boost AAV vector yields in HEK293 manufacturing system

Virica Biotech has announced a collaboration with FUJIFILM Biosciences to co-develop an off-the-shelf enhancer-media solution combining Virica's VSE technology with FUJIFILM's BalanCD HEK293 system, targeting improved AAV productivity and process robustness for gene therapy manufacturers

Ofichem consolidates six brands into single integrated CDMO and pharmaceutical supplier identity

Dutch family-owned pharmaceutical company Ofichem has unified its six business units — spanning API, drug substance, drug product and distribution — under a single trading name
You need to be a subscriber to read this article.
Click here to find out more.

Accelerating the development of bispecific antibodies

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains how the use of comprehensive tailored approaches can enhance bispecific antibody productivity, stability and quality while accelerating their delivery to market

Simplifying continuous operations: lowering the barrier to faster development

Continuous manufacturing has long promised faster development, improved process understanding and, in the absence of scale-up, smoother commercialization. For many pharmaceutical R&D teams, those benefits are well understood. What still holds them back, however, is not scepticism about the concept; it’s the perceived effort required to implement it

More stories

You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Biomarkers: accelerating precision medicine

Using robust biomarker strategies and reliable bioanalytical readouts enables drug developers and clinicians to stratify patients better, interpret responses and advance more tailored, effective therapies, says Ardena CEO Jeremie Trochu
Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets
Sustainability

Samsung Biologics wins Sustainability Leadership Award at 2026 CDMO Leadership Awards

The company received the Sustainability Leadership Award at the 2026 CDMO Leadership Awards, alongside a Best in Class recognition for Cultural Fit, reflecting its efforts to embed sustainable practices across its operations and client partnerships
Ingredients

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Drug Delivery

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Research & Development

Phesi analysis finds 6.7% of global clinical trials affected by Middle East disruption

A Phesi analysis of more than 65,000 active clinical trials has found that 4361 studies are impacted by Middle East disruption, with Phase III oncology trials most exposed and all top ten global pharma companies holding significant investigator site presence in affected countries
Regulatory

UK REACH ATRm: CBA welcomes progress but warns of significant hurdles ahead

The Chemical Business Association has acknowledged long-awaited movement on the UK REACH Alternative Transitional Registration model following DEFRA's consultation response, but cautioned that cost burdens likely running into hundreds of millions of pounds
Finance

Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio

The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Analysis

Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem

As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery challenges
Ingredients

dsm-firmenich launches ModulaSENSE Bitter to tackle bitterness in oral drug formulations

The new taste modulation technology combines bitter blockers, maskers and sweeteners with receptor-based analysis to help pharmaceutical formulators improve the palatability of oral medicines

Sponsor content

Introducing DecFill XP: A New Era in Aseptic Filling

By combining a breakthrough levitating transport system with next‑generation sustainable vials, DecFill XP establishes a new benchmark for compact, energy‑efficient,...

From complexity to confidence: Smurfit Westrock finds a better way to ensure accuracy with EyeC

Demands for printing perfection and regulatory compliance, Smurfit Westrock faced growing complications in producing multilingual pharmaceutical inserts

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"

Lonza Nominates Stephen Fry as Independent Board Member

Basel, Switzerland, 31 March 2026 – The Lonza Board of Directors today announced the nomination of Stephen Fry as an Independent Member of the Board. Subject to his...

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development

PulPac unveils plastic-like fiber caps

The caps will be presented publicly for the first time at interpack 2026, demonstrating how fiber can move into one of the most widely used and technically demanding...

Tekpak Automation to showcase pharma pick-and-place robotic cell at interpack 2026

Tekpak Automation will demonstrate the benefits of robotics for pharmaceutical applications at interpack 2026, with a LIVE working demonstration of a 3-axis pick-and-place...

ImmuneOncia Therapeutics and Lonza collaborate to manufacture Danburstotug

Lonza to support development and manufacturing of ImmuneOncia’s Danburstotug with a complete and integrated end-to-end drug substance and drug product solution

DHS 3000 VSD+ – Atlas Copco's robust screw vacuum pump for industrial application

Compact, quiet and clean

ROIS CDMO closes on the acquisition of US Injectable Manufacturing Facility

This strategic move establishes ROIS as a global Contract Development and Manufacturing Organisation (CDMO), expanding from its existing European operations to now offer...

Marchesini Group at Interpack 2026

Sustainability, primary packaging, aseptic production, robotics and digital innovation at the heart of this edition

Featured companies

PCI Pharma Services: Your bridge between life-changing therapies and patients. Labtex is a specialist laboratory and process chemistry equipment solutions provider. A dynamic team of professionals with expertise in research and process development across... As a dedicated CDMO serving the healthcare industry, we bring life-enhancing and life-saving treatments to market for our customers and their patients. We are a pioneer and... L.B. Bohle is a global acting manufacturer for the pharmaceutical industry. The range of products includes process and handling equipment to produce pharmaceutical solids. As a...
See more

Resource Centre

Latest Media See all

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

From powder to granules: a deep dive into wet granulation methods - WEBINAR NOW ON DEMAND

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with GEA and Hovione

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Piramal Pharma Solutions

Manufacturing Chemist Stand Side with Almac Group

Manufacturing Chemist Stand Side with Almac Group

Latest Reports See all

Panthera joins the Association of Multisite Research Corporations (AMRC)

Membership strengthens Panthera’s ability to collaborate across the industry, contribute to collective advocacy and help shape the future of clinical research

Terminal sterilisation versus aseptic filling: ensuring drug product safety

The sterility of drug products is critical to patient safety. Choosing between terminal sterilisation or aseptic processing to achieve this should reflect the final product’s...

US mRNA policy shift: are vaccine headwinds accelerating oncology focus?

With Washington’s stance on mRNA vaccines cooling, Manufacturing Chemist examines whether policy and funding signals could influence the pharmaceutical industry’s most...

Reimagining biosimilars: faster access, stronger supply, sustainable healthcare

Outdated development models, uneven adoption and policy barriers are holding Europe back. Dr Kevin Robinson (KSR) spoke to Matt Erick (ME), Head of Advanced Markets at Biocon...

Company News

Quibim appoints Itta MacNevin as Chief Business Officer to accelerate global growth and life sciences partnerships Quibim, the global pioneer in imaging biomarkers for precision medicine, is pleased to announce the appointment of Itta MacNevin as Chief Business Officer (CBO). The...
Resyca announces the appointment of Deborah Jones as CEO Dr Jones brings more than 20 years of executive leadership experience driving commercial growth in life sciences technology companies
Germfree appoints Chief Executive Officer Carol Houts brings 30 years of healthcare and life sciences leadership to Germfree’s next phase of growth and execution
Saharsh Davuluri to take over as CEO & MD of Neuland and lead the next phase of CDMO expansion Announcement follows several years of stellar growth and points to a sharper focus on expanding commercial NCE opportunities
Sygnature Discovery strengthens in vivo pharmacology leadership with appointment of Susanne Back The appointment of Susanne Back as Head of In Vivo Pharmacology will further strengthen its bioscience leadership and reinforcing its commitment to delivering high-quality,...
BioDuro appoints Dr. Andrew Thomas and Dr. Stevan Djuric as Scientific Advisors Industry leaders bring decades of pharmaceutical R&D leadership to support BioDuro’s global innovation and clients’ programs
FUJIFILM Biotechnologies Appoints Christiane Bardroff as Chief Business Officer FUJIFILM Biotechnologies, a world-leading contract development and manufacturing organisation (CDMO) for biologics, vaccines, and advanced therapies, announced the appointment...
Envair Technology appoints new sales director to accelerate global growth Orders up 20% year on year as demand for clean air solutions increases across higher education, pharma and healthcare sectors
See more

Upcoming events See all

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK

Cleanroom Technology Conference UK

2026 date TBC | Conference and Exhibition | Birmingham, UK

About Manufacturing Chemist

Through digital, live and print products, Manufacturing Chemist informs and inspires business leaders and decision-makers around the world. With a digital-first strategy, the Group’s Editors write breaking news, product releases, technical papers, innovation features, trend reports and live content agendas covering the entire industry from ingredients and packaging to regulation, retail and marketing.

Pharma 5.0 represents a paradigm shift in pharmaceutical manufacturing, paving the way for a future where medications are developed faster, customised to individual patient needs and delivered with uncompromising quality. It is not just about innovation; it is about transforming the way we think about healthcare and ultimately improving the lives of patients around the world.